Company Overview and News

0
Greenply Industries to list demerged entity Greenpanel in Q4 of FY19

2018-07-16 thehindubusinessline
V Rishi Kumar Greenply Industries, a leading manufacturer of plywood, is likely to see the demerged MDF business listing in the fourth quarter of this fiscal.
526797 GREENPLY

1
Market Live: Sensex gains strength, Nifty reclaims 10,700; Nikkei, Shanghai recover from day#39;s low

2018-07-03 moneycontrol
Market Expert: Dhananjay Sinha, Head of Research, Economist and Strategist, Emkay Global Financial Services told CNBC-TV18 that the announcement of minimum support price (MSP) is critical even if it’s coming with a delay.
GRASIM 500325 UBL MS.PRE MS.PRF MS.PRG MS.PRA ASIANPAINT 532478 534816 MS RLNIY ASHOKLEY GRSJY TATAPOWER YYBKY AKLD MS.PRI 532670 MS.PRK 500180 526797 500300 507458 AKLS BHRYY 500820 RELIANCE IDBI 532737 RENUKA RIGD GREENPLY INFRATEL HDFCBANK 500477 YESBANK 500116 IBN UBHOLDINGS 532648 UNBWY GRSXY ICICIBANK EMKAY HDB 532174 TPCL 500400

1
Market Live: Midcap underperforms Sensex; RIL, TCS, Infosys, HDFC Bank support

2018-07-03 moneycontrol
Govt wants to close IDBI-LIC deal in next three months: Finance Ministry official said insurance major LIC would independently value IDBI Bank, reports CNBC-TV18 quoting NewsRise.
GRASIM BHRYY 500325 500820 RELIANCE IDBI MS.PRE MS.PRF MS.PRG MS.PRA ASIANPAINT 534816 RIGD GREENPLY HDFCBANK 500477 INFRATEL MS RLNIY ASHOKLEY YESBANK GRSJY 500116 IBN TATAPOWER 532648 YYBKY AKLD GRSXY ICICIBANK MS.PRI MS.PRK HDB 532174 500180 526797 500300 TPCL 500400 AKLS

0
Greenply Industries up 5% post commercial production starts at Andhra unit

2018-07-03 moneycontrol
Shares of Greenply Industries added 5.6 percent intraday Tuesday after company commenced commercial production at Andhra unit.
526797 GREENPLY

0
Market Live: Nifty holds 10,650 despite correction in Asian peers; ONGC, Hero top gainers

2018-07-03 moneycontrol
Greenply in Focus: Shares of Greenply Industries added 5.6 percent in morning after company commenced commercial production at Andhra unit.
GRASIM BHRYY 500820 IDBI ASIANPAINT 534816 GREENPLY 500477 INFRATEL ASHOKLEY YESBANK GRSJY 500116 IBN TATAPOWER 532648 YYBKY AKLD GRSXY ICICIBANK 532174 526797 500300 TPCL 500400 AKLS

0
Greenply Industries Limited - Updates

2018-07-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

0
Greenply Industries Limited - AGM/Book Closure

2018-06-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

0
Greenply Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

0
Greenply Industries Limited - Outcome of Board Meeting

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

23
Market Live: Sensex rangebound, PSU Bank index loses 2%; BHEL up 9% on Q4 nos

2018-05-29 moneycontrol
Market Update: Benchmark indices as well as broader markets are in a consolidation mode after sharp rally seen in previous three consecutive sessions. Investors closely monitor the movement in crude oil prices and rupee.
500325 AUROPHARMA RELIANCE 532955 532712 533106 STAR RCOM OIL RIGD 519183 GREENPLY HDFCBANK RLNIY IPCALAB 524804 IBN 538835 BHEL 539207 532531 ICICIBANK 524494 HDB 532174 500180 ARBQY 526797 BRHTY INTELLECT 500103 RECLTD MANPASAND ADFFOODS

20
Market Live: Nifty reclaims 10,700 amid weaker rupee; Vista Pharma up 10%

2018-05-29 moneycontrol
Market Update: The market continued to consolidate after rallying sharply in previous three consecutive sessions. Investors keenly monitor the movement in crude oil prices and rupee.
500325 AUROPHARMA RELIANCE 532955 532712 533106 RCOM OIL RIGD 519183 GREENPLY HDFCBANK RLNIY IPCALAB 524804 IBN 539207 ICICIBANK 524494 HDB 532174 500180 ARBQY 526797 RECLTD MANPASAND ADFFOODS

10
Market Live: Sensex, Nifty consolidate after 3-day rally; weaker rupee lifts IT stocks

2018-05-29 moneycontrol
Buzzing: After being locked in lower circuit on Monday, shares of Manpasand Beverages continued to be locked in the same band today as well, as investors continued to be wary of corporate developments. This is despite the company trying to allay fears around the controversy surrounding its auditor, Deloitte, resigning abruptly.
IPCALAB AUROPHARMA 524804 532955 532712 539207 533106 RCOM 524494 OIL HDB 500180 ARBQY 519183 526797 GREENPLY HDFCBANK RECLTD MANPASAND ADFFOODS

0
Greenply Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

21h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

23h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...